Biogen Inc. (BIIB) announced it has completed the submission of its U.S. marketing application seeking approval of aducanumab for Alzheimer's disease.The Moving Average Convergence Divergence (MACD) oscillator has recently crossed to the upside for a cover shorts buy signal.